Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole

OBJECTIVES: To investigate the incidence of pneumocystis pneumonia (PCP) and its risk factors in patients with rheumatic disease receiving non-high-dose steroid treatment, along with the risks and benefits of PCP prophylaxis. METHODS: This study included 28,292 treatment episodes with prolonged (≥ 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun Won, Curtis, Jeffrey R., Kim, Min Jung, Lee, Hajeong, Song, Yeong Wook, Lee, Eun Bong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744623/
https://www.ncbi.nlm.nih.gov/pubmed/31521185
http://dx.doi.org/10.1186/s13075-019-1996-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744623/
https://www.ncbi.nlm.nih.gov/pubmed/31521185
http://dx.doi.org/10.1186/s13075-019-1996-6

Ejemplares similares